Vistin Pharma ASA (OSL:VISTN)
24.40
+0.30 (1.24%)
At close: Aug 15, 2025
Vistin Pharma ASA Revenue
Vistin Pharma ASA had revenue of 117.67M NOK in the quarter ending June 30, 2025, with 10.92% growth. This brings the company's revenue in the last twelve months to 452.25M, up 2.64% year-over-year. In the year 2024, Vistin Pharma ASA had annual revenue of 429.50M, down -2.01%.
Revenue (ttm)
452.25M
Revenue Growth
+2.64%
P/S Ratio
2.39
Revenue / Employee
6.20M
Employees
75
Market Cap
1.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 429.50M | -8.83M | -2.01% |
Dec 31, 2023 | 438.33M | 133.48M | 43.78% |
Dec 31, 2022 | 304.85M | 26.23M | 9.41% |
Dec 31, 2021 | 278.62M | 24.72M | 9.73% |
Dec 31, 2020 | 253.91M | 25.78M | 11.30% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 603.92M |
Nordhealth AS | 545.88M |
Photocure ASA | 522.86M |
Omda AS | 442.14M |
ArcticZymes Technologies ASA | 102.97M |
Gentian Diagnostics ASA | 163.38M |
Lytix Biopharma AS | 608.00K |
Nykode Therapeutics AS | 87.09M |